Digital Aria Co Ltd (115450) - Total Assets
Based on the latest financial reports, Digital Aria Co Ltd (115450) holds total assets worth ₩228.66 Billion KRW (≈ $154.96 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Digital Aria Co Ltd net assets for net asset value and shareholders' equity analysis.
Digital Aria Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Digital Aria Co Ltd's total assets have evolved over time, based on quarterly financial data.
Digital Aria Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Digital Aria Co Ltd's total assets of ₩228.66 Billion consist of 32.6% current assets and 67.4% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 8.9% |
| Accounts Receivable | ₩14.31 Billion | 6.3% |
| Inventory | ₩7.24 Billion | 3.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩92.12 Billion | 40.3% |
| Goodwill | ₩5.39 Billion | 2.4% |
Asset Composition Trend (2011–2025)
This chart illustrates how Digital Aria Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Digital Aria Co Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Digital Aria Co Ltd's current assets represent 32.6% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 8.9% of total assets in 2025, down from 14.8% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, a decrease from 44.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 40.3% of total assets.
Digital Aria Co Ltd Competitors by Total Assets
Key competitors of Digital Aria Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Digital Aria Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.84 | 1.70 | 2.20 |
| Quick Ratio | 2.57 | 1.53 | 2.05 |
| Cash Ratio | 0.00 | 0.56 | 0.00 |
| Working Capital | ₩48.29 Billion | ₩22.22 Billion | ₩17.54 Billion |
Digital Aria Co Ltd - Advanced Valuation Insights
This section examines the relationship between Digital Aria Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.77 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.0% |
| Total Assets | ₩228.66 Billion |
| Market Capitalization | $210.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Digital Aria Co Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Digital Aria Co Ltd's assets grew by 4.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Digital Aria Co Ltd (2011–2025)
The table below shows the annual total assets of Digital Aria Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩228.66 Billion ≈ $154.96 Million |
+4.03% |
| 2024-12-31 | ₩219.79 Billion ≈ $148.95 Million |
+9.46% |
| 2023-12-31 | ₩200.79 Billion ≈ $136.08 Million |
+7.01% |
| 2022-12-31 | ₩187.64 Billion ≈ $127.16 Million |
-1.09% |
| 2021-12-31 | ₩189.71 Billion ≈ $128.56 Million |
+55.58% |
| 2020-12-31 | ₩121.94 Billion ≈ $82.64 Million |
-12.60% |
| 2019-12-31 | ₩139.52 Billion ≈ $94.55 Million |
+29.60% |
| 2018-12-31 | ₩107.66 Billion ≈ $72.96 Million |
+71.67% |
| 2017-12-31 | ₩62.71 Billion ≈ $42.50 Million |
+21.42% |
| 2016-12-31 | ₩51.65 Billion ≈ $35.00 Million |
+2.58% |
| 2015-12-31 | ₩50.35 Billion ≈ $34.12 Million |
-13.96% |
| 2014-12-31 | ₩58.52 Billion ≈ $39.66 Million |
+59.51% |
| 2013-12-31 | ₩36.69 Billion ≈ $24.86 Million |
-32.46% |
| 2012-12-31 | ₩54.32 Billion ≈ $36.81 Million |
-12.72% |
| 2011-12-31 | ₩62.23 Billion ≈ $42.17 Million |
-- |
About Digital Aria Co Ltd
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more